| Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells CJ Denman, VV Senyukov, SS Somanchi, PV Phatarpekar, LM Kopp, ... PloS one 7 (1), e30264, 2012 | 654 | 2012 |
| Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma) P Anderson, L Kopp, N Anderson, K Cornelius, C Herzog, D Hughes, ... Expert Opinion on Investigational Drugs 17 (11), 1703-1715, 2008 | 92 | 2008 |
| Late effects in adult survivors of pediatric cancer: a guide for the primary care physician LM Kopp, P Gupta, L Pelayo-Katsanis, B Wittman, E Katsanis The American journal of medicine 125 (7), 636-641, 2012 | 76 | 2012 |
| Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions LM Kopp, A Ray, CJ Denman, VS Senyukov, SS Somanchi, S Zhu, ... Molecular Immunology 54 (3), 296-301, 2013 | 66 | 2013 |
| Lifestyle behavior interventions delivered using technology in childhood, adolescent, and young adult cancer survivors: a systematic review LM Kopp, Z Gastelum, CH Guerrero, CL Howe, P Hingorani, M Hingle Pediatric blood & cancer 64 (1), 13-17, 2017 | 61 | 2017 |
| Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the … LM Kopp, S Malempati, M Krailo, Y Gao, A Buxton, BJ Weigel, ... European Journal of Cancer 121, 177-183, 2019 | 55 | 2019 |
| Late health outcomes after dexrazoxane treatment: a report from the Children's Oncology Group EJ Chow, R Aplenc, LM Vrooman, DR Doody, YSV Huang, S Aggarwal, ... Cancer 128 (4), 788-796, 2022 | 39 | 2022 |
| Utility of bone marrow aspiration and biopsy in initial staging of Ewing sarcoma LM Kopp, C Hu, B Rozo, A White‐Collins, WW Huh, A Yarborough, ... Pediatric blood & cancer 62 (1), 12-15, 2015 | 35 | 2015 |
| Clinical trial enrollment of adolescents and young adults with sarcoma LE Davis, KA Janeway, AR Weiss, YLE Chen, TJ Scharschmidt, M Krailo, ... Cancer 123 (18), 3434-3440, 2017 | 33 | 2017 |
| Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group LM Kopp, RB Womer, CL Schwartz, DH Ebb, VI Franco, D Hall, ... Cardio-Oncology 5, 1-12, 2019 | 32 | 2019 |
| All‐trans‐retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia G Quezada, L Kopp, E Estey, RJ Wells Pediatric blood & cancer 51 (1), 133-135, 2008 | 24 | 2008 |
| Dietary interventions for adult survivors of adolescent and young adult cancers: a systematic review and narrative synthesis MB Skiba, JJ McElfresh, CL Howe, TE Crane, LM Kopp, ET Jacobs, ... Journal of adolescent and young adult oncology 9 (3), 315-327, 2020 | 20 | 2020 |
| Incidence of delirium in children with cancer D Combs, SA Rice, LM Kopp Pediatric Blood & Cancer 61 (11), 2094-2095, 2014 | 20 | 2014 |
| Cardiometabolic risk in childhood cancer survivors: a report from the Children's Oncology Group ER Lipshultz, EJ Chow, DR Doody, SH Armenian, BL Asselin, KS Baker, ... Cancer Epidemiology, Biomarkers & Prevention 31 (3), 536-542, 2022 | 18 | 2022 |
| Dexrazoxane and long-term heart function in survivors of childhood cancer EJ Chow, S Aggarwal, DR Doody, R Aplenc, SH Armenian, KS Baker, ... Journal of Clinical Oncology 41 (12), 2248-2257, 2023 | 16 | 2023 |
| Alternative donor hematopoietic cell transplantation conditioned with myeloablative busulfan, fludarabine, and melphalan is well tolerated and effective against high-risk … E Katsanis, LN Sapp, L Pelayo-Katsanis, K Whitney, Y Zeng, LM Kopp Journal of Pediatric Hematology/Oncology 38 (8), e315-e318, 2016 | 14 | 2016 |
| Relationship between individual health beliefs and fruit and vegetable intake and physical activity among cancer survivors: Results from the health information national trends … MB Skiba, ET Jacobs, TE Crane, LM Kopp, CA Thomson Journal of adolescent and young adult oncology 11 (3), 259-267, 2022 | 12 | 2022 |
| Targeted immunotherapy for pediatric solid tumors LM Kopp, E Katsanis Oncoimmunology 5 (3), e1087637, 2016 | 11 | 2016 |
| The effects of dexrazoxane on cardiac status and second malignant neoplasms (SMN) in doxorubicin-treated patients with osteosarcoma (OS). LM Kopp, ML Bernstein, CL Schwartz, D Ebb, MD Krailo, HE Grier, ... Journal of Clinical Oncology 30 (15_suppl), 9503-9503, 2012 | 10 | 2012 |
| ARC-6: A phase 1b/2, open-label, randomized platform study to evaluate efficacy and safety of etrumadenant (AB928)-based treatment combinations in patients with metastatic … SK Subudhi, JC Bendell, MA Carducci, LM Kopp, J Scott, MM Grady, ... Journal of Clinical Oncology 39 (15_suppl), 5039-5039, 2021 | 9 | 2021 |
Emmanuel Katsanis, M.D.University of ArizonaVerified email at peds.arizona.edu
